NCT02882893Unknown2 期
Efficacy and Safety of DWP450 for the Treatment of Crows Feet Lines: Active Controlled, Double-blind, Randomized, Multi-center, Phase II/III Clinical Trial
Daewoong Pharmaceutical Co. LTD.1 个研究点 分布在 1 个国家目标入组 238 人开始时间: 2016年8月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 发起方
- 入组人数
- 238
- 试验地点
- 1
- 主要终点
- Facial Wrinkle Scale(FWS) severity of Crow's feet lines(CFL) at maximum smile as assessed by investigators
研究概览
简要总结
The purpose of this study is to evaluate the Efficacy and Safety of DWP450 treatment of Crows Feet Lines(CFL).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Male or female of at least 18 to 75 years old
- •Bilaterally symmetrical moderate-to-severe CFL at maximum smile on the FWS as rated by the investigator
排除标准
- 未提供
研究组 & 干预措施
DWP450
Experimental
Single-dose
干预措施: Clostridium Botulinum A Toxin (Drug)
Botox
Active Comparator
Single-dose
干预措施: Clostridium Botulinum A Toxin (Drug)
结局指标
主要结局
Facial Wrinkle Scale(FWS) severity of Crow's feet lines(CFL) at maximum smile as assessed by investigators
时间窗: At 4 weeks
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
Unknown
3 期
Efficacy and Safety of DWP450 for Treating Crows Feet Lines(CFL) in Combination With Glabellar Lines(Extension Study)Crow's Feet LinesGlabellar LinesNCT03184363Daewoong Pharmaceutical Co. LTD.102
已完成
3 期
Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar LineModerate to Severe Glabellar LineNCT01629875Daewoong Pharmaceutical Co. LTD.268
已完成
2 期
Evaluate the Efficacy and Safety of DWP05195 in Subjects With Post-Herpetic NeuralgiaPostherpetic NeuralgiaNCT01557010Daewoong Pharmaceutical Co. LTD.140
已完成
3 期
Efficacy and Safety of DWJ1252 in the Treatment of Functional Dyspepsia (PART 2)Functional DyspepsiaNCT03184402Daewoong Pharmaceutical Co. LTD.124
已完成
3 期
Efficacy and Safety of DWJ1252 in the Treatment of Functional DyspepsiaFunctional DyspepsiaNCT03024086Daewoong Pharmaceutical Co. LTD.124